Panfilovich Tatsiana – Trademark Portfolio
Entity Type: 01
Panfilovich Tatsiana holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CANNABIOLOGY EST.2016 and CANNABIOLOGY EST. 2016. The owner is based in Newton, IA.
4308 Morningview Lane Newton IA
Newton, IA 50208
Showing of trademarks Trademarks
Trademark Classifications
Panfilovich Tatsiana's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Panfilovich Tatsiana have?
Panfilovich Tatsiana has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Panfilovich Tatsiana file in?
Panfilovich Tatsiana files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Panfilovich Tatsiana's most well-known trademarks?
Panfilovich Tatsiana's registered trademark portfolio includes well-known marks such as CANNABIOLOGY EST.2016 and CANNABIOLOGY EST. 2016. These are among 2 currently registered trademarks in the portfolio.
What is Panfilovich Tatsiana's trademark registration success rate?
Panfilovich Tatsiana has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.